Tegafur
Teysuno (tegafur) is a small molecule pharmaceutical. Tegafur was first approved as Teysuno on 2011-03-14. It has been approved in Europe to treat stomach neoplasms. It is known to target dihydropyrimidine dehydrogenase [NADP(+)].
Trade Name | Teysuno |
---|---|
Common Name | Tegafur |
Indication | stomach neoplasms |
Drug Class |